Medpace (MEDP) Is Up 5.41% in One Week: What You Should Know

Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the strategy of buying high and selling higher, capitalizing on established price movements [1] - The Zacks Momentum Style Score helps define momentum characteristics, with Medpace (MEDP) currently holding a Momentum Style Score of B [2][3] Group 2: Medpace Performance Metrics - Medpace has shown a 5.41% increase in shares over the past week, outperforming the Zacks Medical Services industry, which rose by 1.6% [5] - Over the past quarter, Medpace shares have risen by 55.26%, and by 18.27% in the last year, compared to the S&P 500's increases of 9.33% and 17.71% respectively [6] - The average 20-day trading volume for Medpace is 772,137 shares, indicating a bullish sign with rising stock prices [7] Group 3: Earnings Outlook - In the past two months, five earnings estimates for Medpace have increased, raising the consensus estimate from $12.71 to $13.99 [9] - For the next fiscal year, five estimates have also moved upwards, with no downward revisions during the same period [9] Group 4: Investment Recommendation - Considering the performance metrics and earnings outlook, Medpace is rated as a 2 (Buy) stock with a Momentum Score of B, making it a potential short-term investment opportunity [11]